BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24094887)

  • 21. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
    Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
    BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma.
    Yang J; Zhong X; Gao X; Xie W; Chen Y; Liao Y; Zhang P
    Cell Adh Migr; 2024 Dec; 18(1):1-12. PubMed ID: 38831518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
    Doberstein K; Wieland A; Lee SB; Blaheta RA; Wedel S; Moch H; Schraml P; Pfeilschifter J; Kristiansen G; Gutwein P
    Carcinogenesis; 2011 Mar; 32(3):262-70. PubMed ID: 21097529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicer, Drosha, and outcomes in patients with ovarian cancer.
    Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
    N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.
    Grelier G; Voirin N; Ay AS; Cox DG; Chabaud S; Treilleux I; Léon-Goddard S; Rimokh R; Mikaelian I; Venoux C; Puisieux A; Lasset C; Moyret-Lalle C
    Br J Cancer; 2009 Aug; 101(4):673-83. PubMed ID: 19672267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of NDRG2 in clear cell renal cell carcinoma.
    Ma J; Jin H; Wang H; Yuan J; Bao T; Jiang X; Zhang W; Zhao H; Yao L
    Biol Pharm Bull; 2008 Jul; 31(7):1316-20. PubMed ID: 18591767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
    Kojima T; Shimazui T; Horie R; Hinotsu S; Oikawa T; Kawai K; Suzuki H; Meno K; Akaza H; Uchida K
    Genes Chromosomes Cancer; 2010 Apr; 49(4):379-89. PubMed ID: 20095040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
    Lu K; Zhao Y; Li Y; Fu Z; Chen Y; Kong Y; Li G
    J Transl Med; 2024 Jun; 22(1):533. PubMed ID: 38831470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
    Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
    Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.
    Ueda R; Kohanbash G; Sasaki K; Fujita M; Zhu X; Kastenhuber ER; McDonald HA; Potter DM; Hamilton RL; Lotze MT; Khan SA; Sobol RW; Okada H
    Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10746-51. PubMed ID: 19520829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway.
    Zhang T; Zhang X; Fei Y; Lu J; Zhou D; Zhang L; Fan S; Zhou J; Liang C; Su Y
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38818827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
    Chiosea S; Jelezcova E; Chandran U; Luo J; Mantha G; Sobol RW; Dacic S
    Cancer Res; 2007 Mar; 67(5):2345-50. PubMed ID: 17332367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.
    Pei X; Li M; Zhan J; Yu Y; Wei X; Guan L; Aydin H; Elson P; Zhou M; He H; Zhang H
    PLoS One; 2015; 10(4):e0124338. PubMed ID: 25919292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential.
    Miyake H; Gleave ME; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 May; 167(5):2203-8. PubMed ID: 11956479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
    Schneider E; Keppler R; Prawitt D; Steinwender C; Roos FC; Thüroff JW; Lausch E; Brenner W
    Int J Oncol; 2011 Mar; 38(3):823-31. PubMed ID: 21206972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression of cathepsin F predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Zhou X; Chen H; Huang D; Guan G; Ma X; Cai W; Liao J; Guan T
    Sci Rep; 2024 Jun; 14(1):13556. PubMed ID: 38866930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway.
    Zhang ZY; Xu JH; Zhang JL; Lin YX; Ou-Yang J
    BMC Cancer; 2024 May; 24(1):650. PubMed ID: 38802739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma.
    Vilà MR; Kaplan GG; Feigelstock D; Nadal M; Morote J; Porta R; Bellmunt J; Meseguer A
    Kidney Int; 2004 May; 65(5):1761-73. PubMed ID: 15086915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.